XLV — State Street Health Care Select Sector SPDR ETF

XLV Price Performance — Growth of $10,000

Value of a $10,000 investment in XLV over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.

XLV Drawdown

The "underwater" chart: XLV's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.

Overview

The State Street Health Care Select Sector SPDR ETF (XLV) is a healthcare-focused fund issued by State Street Investment Management with $43.4 billion in assets. It holds a B grade and ranks second among 11 similar funds, placing it sixth overall across all tracked categories. The fund’s 0.08% expense ratio is significantly lower than the category median of 0.36%, while its 1.51% dividend yield exceeds the median of 1.05%. Concentration is notable, with the top ten holdings representing 61.5% of assets and Eli Lilly & Co comprising the largest single position at 16.5%.

Price action shows the fund trading at 78.1% of its 52-week range, reflecting a recent downgrade from B+ to B on October 2, 2026. Short-term momentum is evident with a 1.39% gain over one month and a 4.49% rise over three months. This acceleration continues into the longer term, where the fund has delivered a 19.09% return over the past year. This one-year performance trails the category median of 19.34% slightly, despite a strong 37.16% return over three years. Historical data is limited to the past three years, which constrains the depth of the long-term record.

Risk metrics indicate a defensive profile, with a beta of 0.52 suggesting the fund moves less than the broader market. Annualized volatility of 15.72% is classified as moderate, contributing to a Sharpe ratio of 0.90. The maximum drawdown of -17.11% highlights the peak-to-trough decline experienced during the available history. Liquidity is robust, supported by an average daily volume of 8,477,355 shares, which facilitates efficient trading.

AI-generated summary based on the data on this page.

XLV Top Holdings

Holdings as of 2026-06-30 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 61.5% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how XLV's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.

Which Funds Overlap With XLV

Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with XLV's top 10 — FHLC overlaps most, holding 9 of the same companies as XLV's top 10 (59.1% of XLV's assets).

Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.

Market Backdrop

10-Year Treasury Yield: 5.27% (as of 2026-10-06) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.

CBOE Volatility Index (VIX): 15.01 (as of 2026-10-06) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.

Federal Funds Rate: 3.75% (as of 2026-09-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.

XLV Liquidity, Domicile & Tax Treatment

Liquidity: Average daily volume is 8.5M/day. Higher volume and a larger fund generally mean lower round-trip trading costs. AUM of $43.4B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.

Domicile & tax treatment: XLV is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.

XLV Performance History

How XLV Compares to Other Healthcare ETFs